Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by EquityInveston May 16, 2018 8:34pm
228 Views
Post# 28042834

Updates on US Cannabis

Updates on US CannabisUp-to-date information on cannabis reforms in the US:

https://www.newswire.ca/news-releases/marapharm-ventures-inc---us-marijuana-reform-bill-historical-first-682782131.html

Short-term, ACB can get a boost with a surprise announcement of an approved Nasdaq listing.  I'm pretty sure that they have applied but did not disclose the actual date of application unlike WEED (I believe that Bruce Linton deliberately announced WEED's application for a Nasdaq 1st thing Monday morning to counter the "bad" news on a Friday afternoon about issuance of 10M shares for various investments).

Also, LEAF has a cannabis-inspired beer "San Rafael" which can attract significant investments from alcohol/liquor corporations.

https://www.stockhouse.com/news/press-releases/2018/02/09/medreleaf-introduces-first-adult-use-recreational-cannabis-brand-san-rafael-71

Any one of these events will significantly boost ACB's sp, plus one tweet from Trump favoring legalization will cement the run - big Pharma/Mutual Funds/Institutional Investors will flock to the biggest player.

For now, best thing to do is wait and be patient.  There are still lots of buyers for ACB shares - we will get through this challenge.  

I'm not ready to get out of ACB.

GLTA

Bullboard Posts